Sequence information
Variant position: 80 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 426 The length of the canonical sequence.
Location on the sequence:
WAVFKGKFKEGDKAEPATWK
T RLRCALNKSPDFEEVTDRSQ
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human WAVFKGKFKEGDKAEPATWKT RLRCALNKSPDFEEVTDRSQ
Mouse WAVFKGKFKEGDKAEPATWKT RLRCALNKSPDFEEVTDRSQ
Chicken WAVFKGKFKEGDKAEPATWKT RLRCALNKSPDFEEVTDRSQ
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
1 – 426
Interferon regulatory factor 8
DNA binding
7 – 114
IRF tryptophan pentad repeat
Literature citations
IRF8 mutations and human dendritic-cell immunodeficiency.
Hambleton S.; Salem S.; Bustamante J.; Bigley V.; Boisson-Dupuis S.; Azevedo J.; Fortin A.; Haniffa M.; Ceron-Gutierrez L.; Bacon C.M.; Menon G.; Trouillet C.; McDonald D.; Carey P.; Ginhoux F.; Alsina L.; Zumwalt T.J.; Kong X.F.; Kumararatne D.; Butler K.; Hubeau M.; Feinberg J.; Al-Muhsen S.; Cant A.; Abel L.; Chaussabel D.; Doffinger R.; Talesnik E.; Grumach A.; Duarte A.; Abarca K.; Moraes-Vasconcelos D.; Burk D.; Berghuis A.; Geissmann F.; Collin M.; Casanova J.L.; Gros P.;
N. Engl. J. Med. 365:127-138(2011)
Cited for: VARIANT IMD32A ALA-80; VARIANT IMD32B GLU-108; CHARACTERIZATION OF VARIANT IMD32A ALA-80; CHARACTERIZATION OF VARIANT IMD32B GLU-108; INVOLVEMENT IN IMD32A; INVOLVEMENT IN IMD32B;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.